NCT06272825

Brief Summary

One of the main challenges facing the therapist in the treatment of adhesive capsulitis is to motivate the patient throughout conventional therapy. As noted in a recent review, individuals are more interested in leisure activities rather than performing repetitive tasks during therapy. Virtual reality (VR) is a three-dimensional computer-aided programme built with a system that creates virtual reality movements and generates a high amount of visual and sensory feedback during exercise. As a result, virtual reality (VR) has been used in many medical indications and has been shown to promote adherence to treatment by increasing patient motivation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable knee-osteoarthritis

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 22, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

May 28, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2025

Completed
Last Updated

August 2, 2024

Status Verified

August 1, 2024

Enrollment Period

7 months

First QC Date

February 14, 2024

Last Update Submit

August 1, 2024

Conditions

Keywords

Knee Osteoarthritisvirtual reailitypainQuality of Life

Outcome Measures

Primary Outcomes (9)

  • Visual Analog Scale

    Visual analog scale (VAS) was used for pain assessment. VAS is a 10-point Likert scale. Patients are asked to indicate their pain level, with 0 points being no pain, 5 points being moderate pain, and 10 points being unbearable pain. Increased scores indicate higher pain levels.

    Baseline

  • Visual Analog Scale

    Visual analog scale (VAS) was used for pain assessment. VAS is a 10-point Likert scale. Patients are asked to indicate their pain level, with 0 points being no pain, 5 points being moderate pain, and 10 points being unbearable pain. Increased scores indicate higher pain levels.

    3th week

  • Visual Analog Scale

    Visual analog scale (VAS) was used for pain assessment. VAS is a 10-point Likert scale. Patients are asked to indicate their pain level, with 0 points being no pain, 5 points being moderate pain, and 10 points being unbearable pain. Increased scores indicate higher pain levels.

    7th week

  • The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    WOMAC was used to assess disability in patients with knee osteoarthritis. The WOMAC assesses pain, stiffness and physical function and consists of 24 items. Total score is between 24 and 120 points. A low score indicates mild illness, a high score indicates severe illness.

    Baseline

  • The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    WOMAC was used to assess disability in patients with knee osteoarthritis. The WOMAC assesses pain, stiffness and physical function and consists of 24 items. Total score is between 24 and 120 points. A low score indicates mild illness, a high score indicates severe illness.

    3th week

  • The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    WOMAC was used to assess disability in patients with knee osteoarthritis. The WOMAC assesses pain, stiffness and physical function and consists of 24 items. Total score is between 24 and 120 points. A low score indicates mild illness, a high score indicates severe illness.

    7th week

  • Biodex Balance System

    The balance assessment of the participants will be made with the Biodex Balance Systems device. During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.

    Baseline

  • Biodex Balance System

    The balance assessment of the participants will be made with the Biodex Balance Systems device. During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.

    3th week

  • Biodex Balance System

    The balance assessment of the participants will be made with the Biodex Balance Systems device. During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.

    7th week

Secondary Outcomes (3)

  • Short Form 36 (SF36)

    Baseline

  • Short Form 36 (SF36)

    3th week

  • Short Form 36 (SF36)

    7th week

Study Arms (2)

Experimental Group

EXPERIMENTAL

In addition to the conventional rehabilitation program at the hospital, virtual reality exercise will be applied in 15 sessions, 5 days a week.

Other: Virtual realityOther: conventional rehabilitation

Control group

ACTIVE COMPARATOR

The conventional rehabilitation program at the hospital will be implemented in 15 sessions, 5 days a week.

Other: conventional rehabilitation

Interventions

VR-based exercise program will be applied in addition to the conventional rehabilitation program, 5 days a week for a total of 3 weeks.

Experimental Group

The conventional exercise program will include 20 minutes(Transcutaneous Electrical Nerve Stimulation) TENS with conventional method, 4 minutes continue ultrason, 20 minutes hot pack.

Control groupExperimental Group

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of chronic (\>3 months) knee osteoarthritis between the ages of 40-85
  • Kellgren and Lawrence Score ≥ 2 on knee radiograph
  • Visual Analogue scale result VAS 4-8

You may not qualify if:

  • Orthopedic surgery performed on the lower extremity
  • Cognitive dysfunction (Mini Mental Test Score \<23)
  • Having received any treatment for knee osteoarthritis in the last 6 months
  • Following any ongoing exercise program (tai chi, pilates, yoga, fitness)
  • History of ligament and ligament injury around the knee

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırşehir Ahi Evran University Faculty of Medicine

Kırşehir, City Center, 40100, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Wi, S. Y., & Kang, J. H. (2012). The effects of virtual reality interactive games on the balance ability of elderly women with knee osteoarthritis. Journal of Korean Society of Physical Medicine, 7(3), 387-393.

    BACKGROUND
  • Lin YT, Lee WC, Hsieh RL. Active video games for knee osteoarthritis improve mobility but not WOMAC score: A randomized controlled trial. Ann Phys Rehabil Med. 2020 Nov;63(6):458-465. doi: 10.1016/j.rehab.2019.11.008. Epub 2020 Jan 22.

    PMID: 31981832BACKGROUND
  • Nambi G, Abdelbasset WK, Elsayed SH, Khalil MA, Alrawaili SM, Alsubaie SF. Comparative effects of virtual reality training and sensory motor training on bone morphogenic proteins and inflammatory biomarkers in post-traumatic osteoarthritis. Sci Rep. 2020 Sep 28;10(1):15864. doi: 10.1038/s41598-020-72587-2.

    PMID: 32985509BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, KneePain

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Basak Cigdem Karacay, Asst Prof

    Kirsehir Ahi Evran University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Basak Cigdem Karacay, Asst Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigator and Outcomes Assessor will be different persons.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised controlled
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 14, 2024

First Posted

February 22, 2024

Study Start

May 28, 2024

Primary Completion

December 14, 2024

Study Completion

January 14, 2025

Last Updated

August 2, 2024

Record last verified: 2024-08

Locations